Sort
40,608 grants matching “prostate cancer”
NEW AWARD - DE NOVO LIPOGENESIS AND CHEMOSENSITIVITY OF PROSTATE CANCER...SIGNED 4/9/2020,EFFECTIVE 5/1/2020,DISTRIBUTED 4/14/2020, FAADC 4/15/2020
$1,207,500Duke University · · FY2020 · Department of the Army
NEW AWARD - TREATMENT OF RADIATION PROCTITIS IN PROSTATE CANCER PATIENTS WITH A NOVEL INDUCER OF AUTOPHAGY...SIGNED 4/23/2020, EFFECTIVE 5/1/2020, DISTRIBUTED 4/27/2020, FAADC 4/27/2020
$1,207,428Duke University · · FY2020 · Defense Health Agency
CANCER AND LEUKEMIA GROUP B CCOP RESEARCH BASE
$1,206,434University Of Chicago · U10 · FY2003 · CA
1/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership
$1,206,257Hala Madanat · San Diego State University · U54 · FY2023 · CA
Transgenic Core Facility
$1,205,803Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,205,526Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2022 · CA
Animal Model and Genotyping Core Support Facility
$1,205,384Wendy Du Bois De Vroylande · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Signal Processing And Instrumentation Section
$1,205,160Thomas J Pohida · Center For Information Technology · ZIA · FY2014 · CT
DEFINING EPIGENETIC DRIVERS OF TREATMENT RESISTANCE IN METASTATIC PROSTATE CANCER
$1,204,942Regents Of The University Of California, San Francisco, The · · FY2022 · Defense Health Agency
National Black Leadership Initiative on Cancer III
$1,204,630Morehouse School Of Medicine · U01 · FY2005 · CA
PRECISION NUTRITION INCREASES EFFICACY OF DNA-DAMAGING THERAPIES IN PROSTATE CANCER
$1,204,278University Of Washington · · FY2022 · Department of the Army
GENETIC EPIDEMIOLOGY OF LUNG CANCER
$1,204,216University Of Cincinnati · U01 · FY2002 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
$1,204,018Daniel B Vigneron · University Of California, San Francisco · U01 · FY2020 · EB
Support for the Central Data Collection Center (CDCC)
$1,203,503Sunitha Mathew · Westat, Inc. · N02 · FY2023 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
$1,203,327Daniel B Vigneron · University Of California, San Francisco · U01 · FY2022 · EB
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$1,202,994Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
IMPROVING INFORMED DECISION-MAKING FOR PRECISION ONCOLOGY IN VETERANS WITH ADVANCED PROSTATE CANCER
$1,202,954Regents Of The University Of California, San Francisco, The · · FY2022 · Defense Health Agency
DEVELOPMENT OF SMALL MOLECULE ACTIVATORS OF PROTEIN PHOSPHATASE 2A (SMAPS) FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
$1,202,262University Of Washington · · FY2015 · Department of the Army
IGF::OT::IGF HHSN261201600007I/HHSN26100001, POP 03/01/2016 - 02/28/2017, PRIMARY PRODUCT/SERVICE CODE TO: B537, DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC), WESTAT
$1,202,227Sunitha Mathew · Westat, Inc. · N02 · FY2016 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
$1,201,901Daniel B Vigneron · University Of California, San Francisco · U01 · FY2023 · EB
Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine
$1,201,880Andrea Califano · Columbia University Health Sciences · U01 · FY2021 · CA
Molecular Epidemiology Studies of Occupational and Environmental Exposures
$1,201,006Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
ENHANCED TARGETING OF CBP/P300 IN A SUBTYPE OF METASTATIC PROSTATE CANCER
$1,200,000Emory University · · FY2022 · Defense Health Agency
OVERCOMING ANDROGEN RECEPTOR-MEDIATED PROSTATE CANCER RESISTANCE TO IMMUNOTHERAPY.
$1,200,000Northwestern University · · FY2021 · Defense Health Agency
Emory Molecular and Translational Imaging Center
$1,200,000Carolyn C. Meltzer · Emory University · P50 · FY2011 · CA